The Type 2 Diabetes Factor Methylglyoxal Mediates Axon Initial Segment Shortening and Alters Neuronal Function at the Cellular and Network Levels
Ryan B. Griggs(University of Kentucky), Keiichiro Susuki(Wright State University)
Cited by 5
Related Papers
Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes
|Journal of Pain|2015|47
Methylglyoxal Requires AC1 and TRPA1 to Produce Pain and Spinal Neuron Activation
|Frontiers in Neuroscience|2017|32
The type 2 diabetes factor methylglyoxal mediates axon initial segment shortening and neuronal network activity changes
|bioRxiv (Cold Spring Harbor Laboratory)|2021|0